Brain atrophy in multiple sclerosis: mechanisms, clinical relevance and treatment options
Athina Andravizou(University of Thessaly), Georgios M. Hadjigeorgiou(University of Thessaly), Georgios Tsivgoulis(University of Tennessee Health Science Center), Efthimios Dardiotis(University of Thessaly), Maria Sokratous(University of Thessaly), Athina‐Maria Aloizou(University of Thessaly), Zisis Tsouris(University of Thessaly), Artemios Artemiadis(National and Kapodistrian University of Athens), Georgia Deretzi(AHEPA University Hospital), Ioannis Nikolaidis(Aristotle University of Thessaloniki), Dimitrios P. Bogdanos(University of Thessaly), Vasileios Siokas(University of Thessaly), Christos Bakirtzis(Aristotle University of Thessaloniki), Nikolaos Grigoriadis(Kingston University)
Cited by 155
Related Papers
A multinational, multicentre study on the psychological outcomes and associated physical symptoms amongst healthcare workers during COVID-19 outbreak
|Brain Behavior and Immunity|2020|1.7k
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
|Science|2019|1.4k
Where are Europe’s last primary forests?
|Diversity and Distributions|2018|454
Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron
|Journal of Neurology Neurosurgery & Psychiatry|2014|355